Elgemtumab(LJM716) is a fully human IgG моноклональный антитело. Elgemtumab can specifically bind to HER3, block лиганд-dependent and independent HER3 signal transduction and клетка proliferation, and has good anti-tumor potential.
Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.